全文获取类型
收费全文 | 20891篇 |
免费 | 1769篇 |
国内免费 | 1949篇 |
出版年
2024年 | 53篇 |
2023年 | 309篇 |
2022年 | 607篇 |
2021年 | 1226篇 |
2020年 | 792篇 |
2019年 | 1051篇 |
2018年 | 986篇 |
2017年 | 734篇 |
2016年 | 1058篇 |
2015年 | 1383篇 |
2014年 | 1684篇 |
2013年 | 1837篇 |
2012年 | 1958篇 |
2011年 | 1802篇 |
2010年 | 1095篇 |
2009年 | 955篇 |
2008年 | 1101篇 |
2007年 | 888篇 |
2006年 | 722篇 |
2005年 | 622篇 |
2004年 | 534篇 |
2003年 | 477篇 |
2002年 | 375篇 |
2001年 | 328篇 |
2000年 | 276篇 |
1999年 | 288篇 |
1998年 | 194篇 |
1997年 | 175篇 |
1996年 | 146篇 |
1995年 | 130篇 |
1994年 | 125篇 |
1993年 | 110篇 |
1992年 | 122篇 |
1991年 | 117篇 |
1990年 | 73篇 |
1989年 | 59篇 |
1988年 | 47篇 |
1987年 | 39篇 |
1986年 | 29篇 |
1985年 | 33篇 |
1984年 | 30篇 |
1983年 | 17篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1950年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
植物ω-3脂肪酸脱氢酶(ω-3FAD)基因是催化亚油酸转化为α-亚麻酸(ALA)的关键酶基因,通过调节该基因的表达,可以提高植物ALA的含量。为了研究温度和紫外照射对紫苏PfFAD7的影响,通过RTPCR方法分析了紫苏地上组织的特异性表达和温度、紫外胁迫下紫苏叶片和茎中PfFAD7基因的积累情况。分析表明,PfFAD7基因在紫苏全植株中均有表达,但在叶片中表达量最高,温度和紫外照射均影响PfFAD7基因的表达,低温可诱导PfFAD7基因的表达,而高温则抑制PfFAD7基因的表达;UV-B照射下,PfFAD7基因在叶片和茎中表达量均表现为先升高再降低。本试验对于紫苏ω-3脂肪酸脱氢酶的研究有利于高水平ALA的积累,更有利于紫苏资源的开发和利用,同时对于进一步了解不饱和脂肪酸的积累和代谢过程以及关键基因PfFAD7在此过程中的功能提供了依据。 相似文献
982.
本研究以总黄酮吸附量和解析率为检测指标,结合动态洗脱考察结果,考察11种树脂对赶黄草总黄酮的富集精制能力。优化树脂类型,选定了对总黄酮进行富集纯化较好的树脂HPD450;采用单因素及正交实验,确定最佳工艺条件:上样量10 mL,以6 mL/min的流速8 BV水、6 BV 80%甲醇溶液洗脱,pH值为6~7。以此方法得到90%以上的赶黄草总黄酮,实验结果良好,总黄酮精制工艺成效显著。用HPLC法精确测定赶黄草中槲皮苷、PGHG和ThA三个指标性黄酮成分,最佳色谱条件为:C18色谱柱,检测波长280 nm,进样量5μL,流动相:乙腈-0.05%磷酸溶液(0~25 min:12%~45%乙腈;25~40 min:45%~70%乙腈)梯度洗脱;精确测定赶黄草全草中3种黄酮成分的含量。采用分光光度法检测,指导优化总黄酮精制工艺,并以HPLC法精确测定三种黄酮代表成分。比较两种方法测定结果相一致,互为补充;故在工业生产时,可以分光光度法指导生产,以HPLC法精确定量测定。 相似文献
983.
本研究采用响应面设计优化超声辅助提取车前总黄酮的最佳条件,然后用此条件提取大车前和平车前总黄酮,并探究大孔树脂纯化对三种车前草总黄酮抗氧化活性的影响。结果表明,在超声温度60℃、乙醇浓度70%的条件下,车前总黄酮最佳提取工艺参数为液料比20:1 m L/g、超声时间80 min、超声功率210 W,车前、大车前和平车前的总黄酮得率分别为5.04%、2.86%和1.22%。无论是纯化前还是纯化后,大车前总黄酮的还原力和对羟基自由基的清除作用最强,平车前最弱;车前总黄酮对DPPH自由基的清除作用最大,平车前最弱。纯化前后的还原力和对DPPH自由基、羟基自由基的清除作用都接近Vc的水平。 相似文献
984.
985.
为探讨针刀联合曲安奈德、正清风痛宁、利多卡因治疗肩周炎的临床疗效及安全性分析,本研究选取2016年1月至2017年12月来东南大学附属中大医院疼痛科就诊肩周炎患者120例,随机数字表法分为药物治疗组40例(曲安奈德+正清风痛宁+利多卡因+臭氧治疗),针刀治疗组40例,综合治疗组40例(曲安奈德+正清风痛宁+利多卡因+臭氧+针刀治疗),对比分析各组治疗前后肩关节功能评分、视觉模拟评分法(visual analogue score, VAS)评分、不良反应发生率。结果显示,组内比较,3组治疗后VAS和肩关节功能评分与治疗前比较,差异具有统计学意义(p<0.001)。组间比较,治疗前3组VAS和肩关节功能评分比较,差异不具有统计学意义;综合治疗组各时间点VAS评分均低于药物及针刀治疗组,综合治疗组肩关节功能评分在治疗后1个月和2个月高于药物及针刀治疗组,差异具有统计学意义(p<0.001)。3组的不良反应发生率,差异不具有统计学意义(p>0.05)。综上所述,针刀治疗联合曲安奈德、正清风痛宁、利多卡因及臭氧在关节腔及关节周围注射治疗肩周炎安全有效,值得在临床中推广应用。 相似文献
986.
<正>Although blood is the most common source for biomarkers,urine has not been completely ignored. There have been some urinary biomarker studies with clinical samples.However, most—if not all—biomarker researchers lack confidence in urine as a good biomarker source. Many researchers think that good results from urine are a statistical accident. To demonstrate the validity of urinary biomarkers,large-scale studies are needed. Until such convincing evidence exists, what funding agent could support research in this field? 相似文献
987.
Grafted embryonic central neural tissue pieces can recover function of hemisected spinal cord in neonatal rats and promote axonal growth in adults. However, spinal cord segments from adults have not been used as donor segments for allogeneic transplantation. Here, we utilized adult spinal cord tissue grafts(aSCGs) as donor constructs for repairing complete spinal cord injury(SCI). Moreover, to provide a favourable microenvironment for SCI treatment, a growth factor cocktail containing three growth factors(brain-derived neurotrophic factor, neurotrophin-3 and vascular endothelial growth factor), was applied to the aSCG transplants. We found that the locomotor function was significantly improved 12 weeks after transplantation of aSCGs into the spinal cord lesion site in adult rats. Transplantation of aSCGs combined with these growth factors enhanced neuron and oligodendrocyte survival and functional restoration. These encouraging results indicate that treatment of complete SCI by transplanting aSCGs, especially in the presence of growth factors, has a positive effect on motor functional recovery, and therefore could be considered as a possible therapeutic strategy for SCI. 相似文献
988.
造血是一个高度协调、精密调控的过程。在正常造血分化过程中, lncRNA不仅调控造血干/祖细胞自我更新、分化、凋亡等过程,还决定造血谱系分化命运。关于lncRNA在人的不同造血谱系分化中的功能以及作用机制的研究已比较深入,但其在红系分化过程中的功能和机制的研究很少,仍处于建立差异基因表达谱的阶段。现有的研究表明, lncRNA-UCA 1(urothelial cancer associated 1)作为原癌基因与多种癌症的发生、发展、转移、产生化疗耐药性等密切相关。该研究发现,在体外诱导脐带血来源的CD34+干/祖细胞向红细胞分化的过程中,采用慢病毒感染的方法敲降UCA 1的表达抑制了红细胞的增殖及活力,对RNA-seq数据进一步分析发现,降低UCA 1的表达会影响与细胞周期相关基因的表达。 相似文献
989.
Hailin Tang Cailu Song Feng Ye Guanfeng Gao Xueqi Ou Lijuan Zhang Xinhua Xie Xiaoming Xie 《Journal of cellular and molecular medicine》2019,23(12):8114-8127
Resistance to trastuzumab remains a major obstacle in HER2‐overexpressing breast cancer treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including tumour recurrence, metastasis and resistance. We hypothesized that miR‐200c contributes to trastuzumab resistance and stemness maintenance in HER2‐overexpressing breast cancer. In this study, we used HER2‐positive SKBR3, HER2‐negative MCF‐7, and their CD44+CD24? phenotype mammospheres SKBR3‐S and MCF‐7‐S to verify. Our results demonstrated that miR‐200c was weakly expressed in breast cancer cell lines and cell line stem cells. Overexpression of miR‐200c resulted in a significant reduction in the number of tumour spheres formed and the population of CD44+CD24? phenotype mammospheres in SKBR3‐S. Combining miR‐200c with trastuzumab can significantly reduce proliferation and increase apoptosis of SKBR3 and SKBR3‐S. Overexpression of miR‐200c also eliminated its downstream target genes. These genes were highly expressed and positively related in breast cancer patients. Overexpression of miR‐200c also improved the malignant progression of SKBR3‐S and SKBR3 in vivo. miR‐200c plays an important role in the maintenance of the CSC‐like phenotype and increases drug sensitivity to trastuzumab in HER2+ cells and stem cells. 相似文献
990.
Yaoyao Wu Qianqian Zhang Yawei Qi Jingjing Gao Wenqiang Li Luxiang Lv Guanjie Chen Zhongjian Zhang Xuyi Yue Shiyong Peng 《Journal of cellular and molecular medicine》2019,23(9):6512-6518
Genome‐wide association studies have confirmed that schizophrenia is an inheritable multiple‐gene mental disorder. Longitudinal studies about depression, first episode psychosis (FEP) and acute psychotic relapse have mostly searched for brain imaging biomarkers and inflammatory markers from the blood. However, to the best of our knowledge, the association between enzymatic activities with diagnosis or prediction of treatment response in people with schizophrenia has barely been validated. Under the Longitudinal Study of National Mental Health Work Plan (2015‐2020), we have studied a subsample of approximately 36 individuals from the cohort with data on palmitoyl‐protein thioesterase‐1 enzymatic activity from FEP and performed a bivariate correlation analysis with psychiatric assessment scores. After adjusting for sex, age, body mass index (BMI) and total serum protein, our data demonstrated that PPT1 enzymatic activity is significantly associated with schizophrenia and its Positive and Negative Syndrome Scale (PANSS) scores. This longitudinal study compared the PPT1 enzymatic activity in FEP schizophrenia patients and healthy volunteers, and the former exhibited a significant 1.5‐fold increase in PPT1 enzymatic levels (1.79 mmol/L/h/mL, and 1.18 mmol/L/h/mL; P < 0.05; 95% CI, 2.3‐2.9 and 1.4‐1.8). The higher PPT1 enzymatic levels in FEP schizophrenia patients were positively associated with larger PANSS scaling scores (r = 0.32, P = 0.0079 for positive scaling; r = 0.41, P = 0.0006 for negative scaling; r = 0.45, P = 0.0001 for general scaling; and r = 0.34, P = 0.0048 for PNASS‐S scaling). Higher enzymatic PPT1 in FEP schizophrenia patients is significantly associated with increased PANSS scaling values, indicating more serious rates of developing psychosis. Enzymatic activity of PPT1 may provide an important new view for schizophrenia disorders. 相似文献